Looks like the real impacts of COVID era mandates are continuing to roll in, well into 2025.
These impacts have ranged from already behind students falling even more behind, if not permanently so, to destroyed businesses to a flat-out distrust of the entire government itself.
And that distrust is likely to further multiply, especially with the latest developments that have emerged from “the science.”
According to a report from Yale News, Ivy League researchers have discovered a new syndrome that may be afflicting many different individuals who received the COVID vaccine: post vaccine syndrome.
A rather serious concern, especially for anyone who has had the COVID vaccine coupled with long term concerns.
“COVID-19 vaccines have been instrumental in reducing the impact of the pandemic, preventing severe illness and death, and they appear to protect against long COVID,” Yale News began.
Right. Though there’s a catch …
“However, some individuals have reported chronic symptoms that developed soon after receiving a COVID-19 vaccine. This little-understood, persistent condition, referred to as post-vaccination syndrome (PVS), remains unrecognized by medical authorities, and little is known about its biological underpinnings,” Yale Newscontinued.
Interesting that medical authorities have apparently chosen to not recognize a study from Yale University.
After all, Yale University is one of the most prominent research institutions in the world, not to mention the alma mater of several individuals who have long been buried deep within the swamp and its political machinations.
Moreover, if scientific researchers at Yale are not “medical authorities” or experts, then who is? Fauci?
The study proceeds to detail various symptoms that individuals may experience from PVS, which individuals struggling with longer term healthcare challenges since the pandemic should be well aware of, for their own sake.
“Some of the most common chronic symptoms of PVS include exercise intolerance, excessive fatigue, brain fog, insomnia, and dizziness. They develop shortly after vaccination, within a day or two, can become more severe in the days that follow, and persist over time,” Yale News mused.
Well. What a lovely array of symptoms.
Sounds like the vaccine should have been vetted a bit more prior to being steamrolled into the marketplace. Especially when considering the profound variations that can emerge on an individual level.
Indeed, the researchers examined immune features that differences between the two groups, finding “several differences in immune cell populations.”
Specifically, “those with [post vaccine syndrome] had lower levels of effector CD4+ T cells and higher levels of TNF-alpha+ CD8 T cells … among other differences,” per Yale News.
Both types of cells –effector CD4+ T cells and TNF-alpha+ CD8 T cells – are also white blood cells.
“Typically spike protein can be detected for a few days after vaccination, but some participants with PVS had detectable levels more than 700 days after their last vaccination. Persistent spike protein has been associated with long COVID as well,” Yale News added.
Well, more great news all around. Even more disturbing that “medical authorities” are apparently refusing to discuss this newly discovered PVS, for whatever reason.
Akiko Iwasaki, who works as a Sterling Professor of Immunobiology at Yale School of Medicine (YSM) and served as a co-senior author of the study, found the elevated protein spikes, especially 700+ days after the last vaccination, “surprising.”
A rather mild assessment, to be sure.
“That was surprising, to find spike protein in circulation at such a late time point. We don’t know if the level of spike protein is causing the chronic symptoms, because there were other participants with PVS who didn’t have any measurable spike protein. But it could be one mechanism underlying this syndrome,” Iwasaki mused.
Without a doubt. A mechanism that will also likely be discovered, in due time.
“This work is still in its early stages, and we need to validate these findings. But this is giving us some hope that there may be something that we can use for diagnosis and treatment of PVS down the road,” Iwasaki added.
One can only hope … especially if there really are far more people vulnerable to PVS than realized.
Harlan Krumholz, who works as the Harold H. Hines, Jr. Professor of Medicine (Cardiology) at Yale and served as the co-senior author of the study, notes that PVS does seem to have an individual impact.
“It’s clear that some individuals are experiencing significant challenges after vaccination. Our responsibility as scientists and clinicians is to listen to their experiences, rigorously investigate the underlying causes, and seek ways to help,” Krumholz continued.
Hopefully, so-called “medical authorities” will be on board with that as well … even if it means admitting some of their past “advice” is quite suspect.
Similar to Iwasaki, Krumholz also notes the wide variance of PVS that might be present in individuals who have received the vaccine.
“One person might develop chronic symptoms due to immune dysregulation, while another experiences lingering effects from viral reactivation. We need to map these different pathways carefully to understand what is happening in each case. This work is just beginning, and further studies are essential to guide diagnosis and treatment,” Krumholz added.
While the work may be “just beginning,” it has clearly already revealed plenty.
One can only imagine how much of the real damage left behind by COVID remains to be exposed …
Author: Ofelia Thornton
These content links are provided by Content.ad. Both Content.ad and the web site upon which the links are displayed may receive compensation when readers click on these links. Some of the content you are redirected to may be sponsored content. View our privacy policy here.
To learn how you can use Content.ad to drive visitors to your content or add this service to your site, please contact us at [email protected].
Family-Friendly Content
Website owners select the type of content that appears in our units. However, if you would like to ensure that Content.ad always displays family-friendly content on this device, regardless of what site you are on, check the option below. Learn More
These content links are provided by Content.ad. Both Content.ad and the web site upon which the links are displayed may receive compensation when readers click on these links. Some of the content you are redirected to may be sponsored content. View our privacy policy here.
To learn how you can use Content.ad to drive visitors to your content or add this service to your site, please contact us at [email protected].
Family-Friendly Content
Website owners select the type of content that appears in our units. However, if you would like to ensure that Content.ad always displays family-friendly content on this device, regardless of what site you are on, check the option below. Learn More
